C
0.730
-0.01 (-1.35%)
| 前收盘价格 | 0.740 |
| 收盘价格 | 0.740 |
| 成交量 | 3,306,000 |
| 平均成交量 (3个月) | 8,068,586 |
| 市值 | 7,016,082,944 |
| 预期市盈率 (P/E Forward) | 24.21 |
| 价格/销量 (P/S) | 1.31 |
| 股市价格/股市净资产 (P/B) | 1.88 |
| 52周波幅 | |
| 利润日期 | 18 Mar 2025 |
| 营业毛利率 | -2.29% |
| 营业利益率 (TTM) | -2.60% |
| 稀释每股收益 (EPS TTM) | -0.010 |
| 季度收入增长率 (YOY) | 5.20% |
| 季度盈利增长率 (YOY) | -97.30% |
| 总债务/股东权益 (D/E MRQ) | 173.70% |
| 流动比率 (MRQ) | 1.28 |
| 营业现金流 (OCF TTM) | 353.53 M |
| 杠杆自由现金流 (LFCF TTM) | 87.52 M |
| 资产报酬率 (ROA TTM) | 0.44% |
| 股东权益报酬率 (ROE TTM) | -3.29% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (HK) | 混合的 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | CKLIFE SCIENCES | - | - |
AIStockmoo 评分
-0.6
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -4.0 |
| 平均 | -0.63 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| CKLIFE SCIENCES | 7 B | - | - | 1.88 |
| CSTONE PHARMA-B | 14 B | - | - | 27.87 |
| VIVA BIOTECH | 4 B | - | 28.57 | 0.940 |
| ANTENGENE-B | 3 B | - | - | 2.84 |
| SINOMAB BIO-B | 2 B | - | - | 4.23 |
| IMMUNOTECH-B | 2 B | - | - | 20.15 |
|
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related and Health. The company derives maximum revenue from the health segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 74.98% |
| 机构持股比例 | 0.31% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合